Tweet Content
Prophylaxis Against PJP in SLE: I'll Pass with @EBRheum
https://t.co/tUGwziEYCg https://t.co/VqTa9jG8oj
Links
Prophylaxis Against PJP in SLE: I'll Pass | RheumNow
https://buff.ly/vda6tua
Congrats to Dr. Virginia Pascual who was elected to American Academy of Arts and Sciences. Virginia isthe director of G
Tweet Content
Congrats to Dr. Virginia Pascual who was elected to American Academy of Arts and Sciences. Virginia isthe director of Gale & Ira Drukier Institute for Children’s Health & Ronay Menschel Professor of Pediatrics @ Weill Cornell Medicine. Her translational/basic research have been https://t.co/hOYi59xMC5
HCQ is lupus health insurance
PETRI-isms: "HCQ is lupus health insurance." - Michelle Petri, MD
Stable SLE - Should you Withdraw Immunosuppressant or Glucocorticoids? An open-label, single-centre, randomized contro
Tweet Content
Stable SLE - Should you Withdraw Immunosuppressant or Glucocorticoids?
An open-label, single-centre, randomized controlled trial tested whether immunosuppressant (IS) withdrawal is noninferior to glucocorticoid (GC) withdrawal in SLE patients and found that IS withdrawal is https://t.co/T8Fu83GScH
Glucocorticoids in SLE: how to start, how to follow, how to stop More than 70 years after their first use in rheumatol
Tweet Content
Glucocorticoids in SLE: how to start, how to follow, how to stop
More than 70 years after their first use in rheumatology by Philip Hench, glucocorticoids (GCs) continue to be one of the main weapons to fight systemic lupus erythematosus (SLE). No other available medication https://t.co/H6N0N3BhhU
Pitfalls in sacroiliitis imaging: Bone marrow edema may also be seen in young-middle-aged postpartum women, & athlet
Tweet Content
Pitfalls in sacroiliitis imaging: Bone marrow edema may also be seen in young-middle-aged postpartum women, & athletes & kids (ongoing bone growth) & w/ advancing age (DJD) https://t.co/bwS047wlmI https://t.co/FvWlEcZ5JP
Links
Pearls and pitfalls in imaging of axial spondyloarthritis for rheumatologists
https://buff.ly/I1dPR43
single-centre study of 469 consecutive RA pts - 15 had VTE (3%). Strongest risk factor of VTE was the history of previou
Tweet Content
single-centre study of 469 consecutive RA pts - 15 had VTE (3%). Strongest risk factor of VTE was the history of previous VTE (OR 44.7), recent hospitalisation (OR 6.82), diabetes (OR 11.23), and JAKi (OR 5.54) (Other studies show inflammation incr VTE risk) https://t.co/pBJDhXOgut